BSE See NSE See 52,653.07
209.36 (0.4%)

KPIT Technologies reports strong performance in Q1FY22; share gains on Tuesday

The stock has delighted investors by delivering gains of 347.35 per cent in the last one year & 108.03 per cent in 2021, so far.

Shreya Chaware / Article rating: 3.3

KPIT Technologies, an Indian multinational corporation, announced its quarterly results for Q1FY22. During the year, the company has also entered T25 engagements across geographies.

Jindal Stainless rallies 5 per cent on posting strong Q1 results; announces Rs 2,150 crore expansion plan

The estimated Capex of this brownfield expansion is Rs 2,150 crore. The three-pronged expansion plan envelopes the expansion of melting capacity and commensurate strengthening of forward as well as backward linkages.

Armaan Madhani / Article rating: 3.0

The company accelerated its deleveraging strategy during the quarter and narrowed long-term external debt (excluding group company JSHL’s debt) by Rs 210 crore.

Biocon Biologics partners with Adagio Therapeutics to advance antibody for COVID-19 prevention & treatment

ADG20 is a novel monoclonal antibody, targeting the spike protein of related Coronaviruses and SARS-CoV-2. It is currently in global clinical development by Adagio as a single agent for both prevention and treatment of Coronavirus.

Armaan Madhani / Article rating: 4.0

The fully-integrated biosimilars company, Biocon Biologics Ltd, a subsidiary of Biocon Ltd reported that US-based Adagio Therapeutics has granted them an exclusive licence to manufacture and commercialise, broadly neutralising antibody treatment based on ADG20 for India as well as select emerging markets. 


Get A Call From Industry Experts

Send Otp

   I authorize DSIJ Pvt Ltd to contact me. This will override registry on the NDNC.